Progress toward a molecular characterization of cancer would have important clinical benefits; thus, there is an important need to image the molecular features of cancer in vivo. In this paper, we describe a comprehensive strategy to develop inexpensive, rugged and portable optical imaging systems for molecular imaging of cancer, which couples the development of optically active contrast agents with advances in functional genomics of cancer. We describe initial results obtained using optically active contrast agents to image the expression of three well known molecular signatures of neoplasia: including over expression of the epidermal growth factor receptor (EGFR), matrix metallo-proteases (MMPs), and oncoproteins associated with human papillomavirus (HPV) infection. At the same time, we are developing inexpensive, portable optical systems to image the morphologic and molecular signatures of neoplasia noninvasively in real time. These real-time, portable, inexpensive systems can provide tools to characterize the molecular features of cancer in vivo.
References
1.
OrganizationW. H.Cancer Control (1996).
2.
FraterJ. L.Chronic Myeloid Leukemia Following Therapy with Imatinib Mesylate (Gleevec). Bone Marrow Histopathology and Correlation with Genetic Status. American Journal of Clinical Pathology119, 833–841 (2003).
3.
YeeK. W.KeatingA.Advances in Targeted Therapy for Chronic Myeloid Leukemia. Expert Review of Anticancer Therapy3, 295–310 (2003).
4.
PomperM. G.Molecular Imaging: An Overview. Academic Radiology8, 1141–1153 (2001).
5.
RajadhyakshaM.In Vivo Confocal Scanning Laser Microscopy of Human Skin: Melanin Provides Strong Contrast. Journal of Investigative Dermatology104, 946–952 (1995).
6.
RajadhyakshaM.AndersonR. R.WebbR. H.Video-rate Confocal Scanning Laser Microscope for Imaging Human TissuesIn Vivo. Applied Optics38, 2105–2115 (1999).
7.
RajadhyakshaM.In Vivo Confocal Scanning Laser Microscopy of Human Skin II: Advances in Instrumentation and Comparison with Histology. Journal of Investigative Dermatology, 113, 293–303 (1999).
8.
RajadhyakshaM.Confocal Examination of Nonmelanoma Cancers in Thick Skin Excisions to Potentially Guide Mohs Micrographic Surgery Without Frozen Histopathology. The Journal of Investigative Dermatology117, 1137–1143 (2001).
9.
RajadhyakshaM.Confocal Cross-Polarized Imaging of Skin Cancers to Potentially Guide Mohs Micrographic Surgery. Optics & Photonics News, 30 (2001).
10.
SelkinB.In Vivo Confocal Microscopy in Dermatology. Dermatologic Clinics19, 369–377 (2001).
11.
WhiteW. M.Noninvasive Imaging of Human Oral Mucosa In Vivo by Confocal Reflectance Microscopy. Laryngoscope109, 1709–1717 (1999).
12.
GonzalezS.Confocal Reflectance Imaging of Folliculitis In Vivo: Correlation with Routine Histology. Journal of Cutaneous Pathology26, 201–205 (1999).
13.
GonzálezS.Allergic Contact Dermatitis: Correlation of In Vivo Confocal Imaging to Routine Histology. Journal of the American Academy of Dermatology40, 708–713 (1999).
14.
GonzálezS.Characterization of Psoriasis In Vivo by Reflectance Confocal Microscopy. Journal of Medicine30, 337–56 (1999).
15.
GonzálezS.In Vivo Abnormal Keratinazation in Darier-White's Disease as Viewed by Real-time Confocal Imaging. Journal of Cutaneous Pathology26, 504–508 (1999).
16.
GonzálezS.Confocal Imaging of Sebaceous Gland Hyperplasia In Vivo to Assess Efficacy and Mechanism of Pulsed Dye Laser Treatment. Lasers in Surgery and Medicine25, 8–12 (1999).
17.
HuzairaM.Topographic Variations in Normal Skin, as Viewed by In Vivo Reflectance Confocal Microscopy. The Journal of Investigative Dermatology116, 846–852 (2001).
18.
LangleyR. G.Confocal Scanning Laser Microscopy of Benign and Malignant Melanocytic Skin LesionsIn Vivo. Journal of the American Academy of Dermatology45, 365–376 (2001).
19.
CollierT.Near Real-Time Confocal Microscopy of Amelanotic Tissue: Detection of Dysplasia in Ex Vivo Cervical Tissue. Academic Radiology9, 504–512 (2002).
20.
CollierT.Near Real Time Confocal Microscopy of Amelanotic Tissue: Dynamics of Aceto-Whitening Enable Nuclear Segmentation. Optics Express6, 40–48 (2000).
21.
CollierT.Fiber-Optic Confocal Microscope for Biological Imaging. in Conference on Lasers and Electro-Optics. San Francisco, CA: Institute of Electrical and Electronics Engineers (1998).
22.
St CroixB.Genes Expressed in Human Tumor Endothelium. Science289, 1197–1202 (2000).
23.
HibiK.Advances in Brief — Serial Analysis of Gene Expression in Non-Small Cell Lung Cancer. Cancer Research: The Official Organ of the American Association for Cancer Research58, 5690–5694 (1998).
24.
LalA.Advances in Brief — A Public Database for Gene Expression in Human Cancers. Cancer Research: The Official Organ of the American Association for Cancer Research59, 5403–5407 (1999).
25.
KoloninM.PasqualiniR.ArapW.Molecular Addresses in Blood Vessels as Targets for Therapy. Current Opinion in Chemical Biology5, 308–313 (2001).
26.
ArapW.Targeting the Prostate for Destruction Through a Vascular Address. Proceedings of the National Academy of Sciences of the United States of America99, 1527–1531 (2002).
27.
TakahaN.High Mobility Group Protein I(Y): A Candidate Architectural Protein for Chromosomal Rearrangements in Prostate Cancer Cells. Cancer Res. (2002).
28.
CondeelisJ.The Biochemistry of Animal Cell Crawling, in Motion Analysis of Living Cells. pp. 85–100. Ed., SollD.. Wiley Liss, Inc (1988).
29.
BaillyM.Relationship Between Arp2/3 Complex and the Barbed Ends of Actin Filaments at the Leading Edge of Carcinoma Cells after Epidermal Growth Factor Stimulation. J. Cell Biol. (1999).
30.
CondeelisJ. S.WyckoffJ.SegallJ. E.Imaging of Cancer Invasion and Metastasis using Green Fluorescent Protein. European Journal of Cancer36, 1671–1680 (2000).
31.
GohongiT.Tumor-host Interactions in the Gallbladder Suppress Distal Angiogenesis and Tumor Growth: Involvement of Transforming Growth Factor Beta1. Nature Medicine5, 1203–1208 (1999).
32.
BrownE. B.In Vivo Measurement of Gene Expression, Angiogenesis and Physiological Function in Tumors using Multiphoton Laser Scanning Microscopy. Nature Medicine7, 864–868 (2001).
33.
CarmelietP.JainR. K.Angiogenesis in Cancer and other Diseases. Nature407, 249–257 (2000).
34.
van de VijverM. J.A Gene-Expression Signature as a Predictor of Survival in Breast Cancer. The New England Journal of Medicine347, 1999–2009 (2002).
35.
AngK. K.Impact of Epidermal Growth Factor Receptor Expression on Survival and Pattern of Relapse in Patients with Advanced Head and Neck Carcinoma. Cancer Research62, 7350–7356 (2002).
36.
HanahanD.WeinbergR. A.The Hallmarks of Cancer. Cell, 100, 57–70 (2000).
37.
LinC. R.Expression Cloning of Human EGF Receptor Complementary DNA: Gene Amplification and Three Related Messenger RNA Products in A431 Cells.
38.
UllrichA.CoussensL.HayflickJ. S.DullT. J.GrayA.TamA. W.LeeJ.YardenY.LibermannT. A.Human Epidermal Growth Factor Receptor cDNA Sequence and Aberrant Expression of the Amplified Gene in A431 Epidermoid Carcinoma Cells. Nature309, 418–425 (1984).
39.
XuY. H.Human Epidermal Growth Factor Receptor cDNA is Homologous to a Variety of RNAs Overproduced in A431 Carcinoma Cells. Nature309, 806–810 (1984).
40.
KersemaekersA. M.Oncogene Alterations in Carcinomas of the Uterine Cervix: Overexpression of the Epidermal Growth Factor Receptor is Associated with Poor Prognosis. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research5, 577–586 (1999).
41.
ChangJ. L.The Expression of Type I Growth Factor Receptors in the Squamous Neoplastic Changes of Uterine Cervix. Gynecologic Oncology73, 62–71 (1999).
42.
NishiokaT.Prognostic Significance of c-erbB-2 Protein Expression in Carcinoma of the Cervix Treated with Radiotherapy. Journal of Cancer Research and Clinical Oncology125, 96–100 (1999).
43.
MathevetP.FrappartL.HittelmanW.Dysplasies du col utérin: étude des expressions des gènes Rb et p53, et corrélation avec l'activité mitotique. Gynecologie, Obstetrique & Fertilite28, 44–50 (2000).
44.
ShinD. M.Expression of Epidermal Growth Factor Receptor, Polyamine Levels, Ornithine Decarboxylase Activity, Micronuclei, and Transglutaminase I in a 7,12-dimethylbenz(a)anthracene-induced Hamster Buccal Pouch Carcinogenesis Model. Cancer Research50, 2505–2510 (1990).
45.
ToddR.WongD. T.. Epidermal Growth Factor Receptor (EGFR) Biology and Human Oral Cancer. Histology and Histopathology14, 491–500 (1999).
46.
AverbuchS. D.Lung Cancer Prevention: Retinoids and the Epidermal Growth Factor Receptor-a Phoenix Rising?Clinical Cancer Research: An Official Journal of the American Association for Cancer Research8, 1–3 (2002).
47.
SpornM. B.The War on Cancer. Lancet347, 1377–1381 (1996).
GarzettiG. G.Microinvasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia: Biologic Significance and Clinical Implications of 72-kDa Metalloproteinase Immunostaining. Gynecologic Oncology61, 197–203 (1996).
50.
TalvensaariA.Matrix Metalloproteinase 2 Immunoreactive Protein Appears Early in Cervical Epithelial Dedifferentiation. Gynecologic Oncology72, 306–311 (1999).
51.
Daneri-NavarroA.Proteolytic Activity in Extracts of Invasive Cervical Carcinoma and Precursor Lesions. Biomedicine & Pharmacotherapy49, 304–310 (1995).
52.
McCluggageW. G.MaxwellP.BharuchaH.Immunohistochemical Detection of Metallothionein and MIB1 in Uterine Cervical Squamous Lesions. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists17, 29–35 (1998).
53.
DavidsonB.Expression of Matrix Metalloproteinase-9 in Squamous Cell Carcinoma of the Uterine Cervix — Clinicopathologic Study Using Immunohistochemistry and mRNA In Situ Hybridization. Gynecologic Oncology72, 380–386 (1999).
54.
SienelW.Prognostic Impact of Matrix Metalloproteinase-9 in Operable Non-small Cell Lung Cancer. International Journal of Cancer103, 647–651 (2003).
55.
PasslickB.Overexpression of Matrix Metalloproteinase 2 Predicts Unfavorable Outcome in Early-stage Non-small Cell Lung Cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research6, 3944–3948 (2000).
56.
HrabecE.Activity of Type IV Collagenases (MMP-2 and MMP-9) in Primary Pulmonary Carcinomas: A Quantitative Analysis. Journal of Cancer Research and Clinical Oncology128, 197–204 (2002).
57.
MunozN.HPV and Cervical Neoplasia: Review of Case-control and Cohort Studies. IARC Sci Publ119, 251–261 (1992).
KlaesR.Detection of High Risk Cervical Intraepithelial Neoplasia and Cervical Cancer by Amplification of Transcripts Derived from Integrated Papillomavirus Oncogenes. Cancer Research59, 132–136 (1999).
60.
AlbertsB.Molecular Biology of the Cell. New York: Garland Publishing (1994).
61.
DrezekR. A.Laser Scanning Confocal Microscopy of Cervical Tissue Before and After Application of Acetic Acid. American Journal of Obstetrics and Gynecology182, 1135–1139 (2000).
62.
DelaneyP. M.HarrisM. R.Fiber Optics in Confocal Microscope in Handbook of Confocal Microscopy. pp. 515–523. Ed., PawleyJ. B.Plenum Press: New York (1995).
63.
SmithpeterC. L.Near Real Time Confocal Microscopy of Cultured Amelanotic Cells: Sources of Signal, Contrast Agents, and Limits of Contrast. Journal of Biomedical Optics3, 429–436 (1998).
64.
MinskyM.Microscopy Apparatus. U. S. Patent 301467 (1961).
65.
LiangC.Design of a High-numerical-aperture Miniature Microscope Objective for an Endoscopic Fiber Confocal Reflectance Microscope. Applied Optics41, 4603–4610 (2002).
66.
SungK. B.Near Real Time In Vivo Fibre Optic Confocal Microscopy: Sub-cellular Structure Resolved. Journal of Microscopy207, 137–145 (2002).
67.
SungK.-B.Fiber-Optic Confocal Reflectance Microscope With Miniature Objective for In Vivo Imaging of Human Tissues. IEEE Transactions on Biomedical Engineering49, 1168–1172 (2002).
68.
HornbeckL. J.Digital Light Processing and MEMS: Reflecting the Digital Display Needs of the Networked Society in SPIE/EOS European Symposium on Lasers, Optics, and Vision for Productivity in Manufacturing 1, Conference on Micro-Optical Tech. For Measurement, Sensors & Microsystems. Besacon, France (1996).
69.
LaneP. M.Medical Optics and Biotechnology — Fiber-optic Confocal Microscopy using a Spatial Light Modulator. Optics Letters25, 1780–1782 (2000).
70.
BenavidesJ. M.Multispectral Digital Colposcopy for In Vivo Detection of Cervical Cancer. Optics Express11, 1223–1236 (2003).
71.
HorisbergerM.Colloidal Gold: A Cytochemical Marker for Light and Fluorescent Microscopy and for Transmission and Scanning Electron Microscopy. Scan Electron Microsc2, 9–31 (1981).
72.
GeogheganW. D.AckermanG. A.Adsorption of Horseradish Peroxidase, Ovomucoid and Anti-immunoglobulin to Colloidal Gold for the Indirect Detection of Concanavalin A, Wheat Germ Agglutinin and Goat Anti-human Immunoglobulin G on Cell Surfaces at the Electron Microscopic Level: A New Method, Theory and Application. The Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society, 25, 1187–1200 (1977).
73.
MulvaneyP.Surface Plasmon Spectroscopy of Nanosized Metal Particles. Langmuir12, 788–800 (1996).
74.
NabievI. R.MorjaniH.ManfaitM.Selective Analysis of Antitumor Drug Interaction with Living Cancer Cells as Probed by Surface-enhanced Raman Spectroscopy. European Biophysics Journal19, 311–316 (1991).
75.
KneippK.Surface-Enhanced Raman Spectroscopy in Single Living Cells Using Gold Nanoparticles. Applied Spectroscopy56, 150–154 (2002).
76.
NieS.EmoryS. R.Probing Single Molecules and Single Nanoparticles by Surface-enhanced Raman Scattering. Science275, 1102–1106 (1997).
77.
ElghanianR.Selective Colorimetric Detection of Polynucleotides Based on the Distance-dependent Optical Properties of Gold Nanoparticles. Science277, 1078–1080 (1997).
78.
YasudaR.Resolution of Distinct Rotational Substeps by Submillisecond Kinetic Analysis of F1-ATPase. Nature410, 898–904 (2001).
79.
SchultzS.Single-target Molecule Detection with Nonbleaching Multicolor Optical Immunolabels. Proceedings of the National Academy of Sciences of the United States of America97, 996–1001 (2000).
80.
SokolovK.Real-time Vital Optical Imaging of Precancer using Anti-epidermal Growth Factor Receptor Antibodies Conjugated to Gold Nanoparticles. Cancer Research63, 1999–2004 (2003).
81.
CarpenterG.Receptors For Epidermal Growth Factor And Other Polypeptide Mitogens. Annual Review of Biochemistry56, 881–914 (1987).
82.
SokolovK.Realistic Three-dimensional Epithelial Tissue Phantoms for Biomedical Optics. Journal of Biomedical Optics7, 148–156 (2002).
83.
Hahn-DantonaE.The Low Density Lipoprotein Receptor-related Protein Modulates Levels of Matrix Metalloproteinase 9 (MMP-9) by Mediating its Cellular Catabolism. The Journal of Biological Chemistry276, 15498–15503 (2001).
84.
FriedlP.BrockerE.-B.The Biology of Cell Locomotion within Three-dimensional Extracellular Matrix. Cellular and Molecular Life Sciences57, 41–64 (2000).
85.
AbramsM. J.MurrerB. A.Metal Compounds in Therapy and Diagnosis. Science261, 725–730 (1993).
86.
BerkowerI.The Promise and Pitfalls of Monoclonal Antibody Therapeutics. Current Opinion in Biotechnology7, 622–628 (1996).
87.
HolligerP.BohlenH.Engineering Antibodies for the Clinic. Cancer and Metastasis Reviews18, 411–419 (1999).
88.
WeinerL. M.An Overview of Monoclonal Antibody Therapy of Cancer. Seminars in Oncology26, 41–50 (1999).
89.
SoukosN. S.Epidermal Growth Factor Receptor-targeted Immunophotodiagnosis and Photoimmunotherapy of Oral Precancer In Vivo. Cancer Research61, 4490–4496 (2001).
90.
AchilefuS.New Approach to Optical Imaging of Tumors. Proceedings of SPIE: Biomarkers and Biological Spectral Imaging. San Jose, CA (2001).
91.
AchilefuS.Site-specific Tumor Targeted Fluorescent Contrast Agents. Proceedings of SPIE: Clinical Lasers and Diagnostics. Amsterdam (2001).
92.
BugajJ. E.Novel Fluorescent Contrast Agents for Optical Imaging of In Vivo Tumors Based on a Receptor-targeted Dye-peptide Conjugate Platform. Journal of Biomedical Optics6, 122–133 (2001).
93.
TungC. H.A Receptor-targeted Near-infrared Fluorescence probe for In Vivo Tumor Imaging. Chembiochem3, 784–786 (2002).
94.
BeckerA.Receptor-targeted Optical Imaging of Tumors with Near-infrared Fluorescent Ligands. Nature Biotechnology19, 327–31 (2001).
95.
BremerC.TungC. H.WeisslederR.In Vivo Molecular Target Assessment of Matrix Metalloproteinase Inhibition. Nature Medicine7, 743–748 (2001).
96.
TungC. H.In Vivo Imaging of Proteolytic Enzyme Activity using a Novel Molecular Reporter. Cancer Research60, 4953–4958 (2000).
97.
FarinaK. L.Cell Motility of Tumor Cells Visualized in Living Intact Primary Tumors using Green Fluorescent Protein. Cancer Research58, 2528–2532 (1998).
98.
BornhopD. J.Advance in Contrast Agents, Reporters, and Detection. Journal of Biomedical Optics6, 106–110 (2001).
99.
DesmettreT.DevoisselleJ. M.MordonS.Fluorescence Properties and Metabolic Features of Indocyanine Green (ICG) as Related to Angiography. Survey of Ophthalmology45, 15–27 (2000).
100.
SlakterJ. S.Indocyanine-green Angiography. Current Opinion in Ophthalmology6, 25–32 (1995).
101.
HaglundM. M.BergerM.S.HochmanD.W.Enhanced Optical Imaging of Human Gliomas and Tumor Margins. Neurosurgery38, 308–317 (1996).
102.
AnikijenkoP.In Vivo Detection of Small Subsurface Melanomas in Athymic Mice using Noninvasive Fiber Optic Confocal Imaging. The Journal of Investigative Dermatology117, 1442–1448 (2001).
103.
ItoS.Detection of Human Gastric Cancer in Resected Specimens using a Novel Infrared Fluorescent Anti-human Carcinoembryonic Antigen Antibody with an Infrared Fluorescence EndoscopeIn Vitro. Endoscopy33, 849–53 (2001).
104.
BaninU.Size-dependent Electronic Level Structure of InAs Nanocrystal Quantum Dots: Test of Multiband Effective Mass Theory. Journal of Chemical Physics 109, 2306 (1998).
105.
MurrayC. B.NorrisD. J.BawendiM. G.Synthesis and Characterization of Nearly Monodisperse CdE (E = Sulfur, Selenium, Tellurium) Semiconductor Nanocrystallites. Journal of the American Chemical Society115, 8706–8715 (1993).
106.
LacosteT. D.Ultrahigh-resolution Multicolor Colocalization of Single Fluorescent Probes. Proceedings of the National Academy of Sciences of the United States of America97, 9461–6 (2000).
107.
ChanW. C.Luminescent Quantum Dots for Multiplexed Biological Detection and Imaging. Current Opinion in Biotechnology13, 40–46 (2002).
108.
ParakW. J.Cell Motility and Metastatic Potential Studies based on Quantum Dot Imaging of Phagokinetic Tracks. Advanced Materials14, 882–885 (2002).
109.
AkermanM. E.Nanocrystal TargetingIn Vivo. Proceedings of the National Academy of Sciences of the United States of America, 99, 12617–12621 (2002).
110.
DubertretB.In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles. Science298, 1759–1762 (2002).
111.
BruchezM.Jr.Semiconductor Nanocrystals as Fluorescent Biological Labels. Science281, 2013–2016 (1998).
